I have to say this stock is probably quite undervalued
Valens make circa $200m gross revenue per annum and according to their website, Epsilon will be their sole EU GMP manufacturing site for export to the whole EU market.
It also says in their news releases that they currently are the contract extractors for 7 out of the top 10 cannabis companies globally.
if they bring these same clients to EPN for their EU sales, I'm expecting this stock to light up the stairs.
IMHO DYOR GLTA
Ann: Epsilon Enters Exclusive Partnership with The Valens Company, page-34
Add EPN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.208M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| EPN (ASX) Chart |
Day chart unavailable